摘要 |
Disclosed is a method for relieving symptoms associated with illness or discomfort associated with the treatment of illness in a subject. The method includes providing a cannabinoid composition and delivering the cannabinoid transdermally to the subject. The cannabinoid composition used in this method includes at least one cannabinoid selected from the group consisting of DELTA9-THC, cannabinol, cannabidiol, nabilone, levonantradol, (-)-HU-210, (+)-HU-210, 11-hydroxy-DELTA9-THC, DELTA8-THC-11-oic acid, CP 55,940, and R(+)-WIN 55,212-2. Also disclosed is an occlusive body which includes an impermeable backing and a rate-controlling microporous membrane which together define a cavity in which a cannabinoid is disposed. Methods for increasing the concentration of cannabinoids or cannabinoid metabolites in a subject and for assessing the permeability of skin to cannabinoids are also described.
|